chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by an other health care professional and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 09-May-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.  The patient had established prenatal care. There was no complications or acute illness reported during tis pregnancy. Number of fetuses was reported as 1.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Breast discomfort, Breast swelling, Computerised tomogram, Fibrin D dimer
Clinical narrative: Breast heaviness; chest pain; Breast swelling; Sprain; This spontaneous case was reported by a nurse and describes the occurrence of BREAST DISCOMFORT (Breast heaviness), MUSCULOSKELETAL CHEST PAIN (chest pain), BREAST SWELLING (Breast swelling) and LIGAMENT SPRAIN (Sprain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 09-Jan-2021, the patient experienced BREAST DISCOMFORT (Breast heaviness), MUSCULOSKELETAL CHEST PAIN (chest pain), BREAST SWELLING (Breast swelling) and LIGAMENT SPRAIN (Sprain). At the time of the report, BREAST DISCOMFORT (Breast heaviness), MUSCULOSKELETAL CHEST PAIN (chest pain), BREAST SWELLING (Breast swelling) and LIGAMENT SPRAIN (Sprain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: Hypertension. On an unknown date, Computerised tomogram: negative (Negative) Unclear. On an unknown date, Fibrin D dimer: d-dimer Elevated, rule out DVT. On an unknown date, X-ray: x-ray Not clear.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included motrin and Lidoderm patch.  No concomitant medication was provided.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Ligament sprain, Musculoskeletal chest pain, X-ray
Clinical narrative: Breast heaviness; chest pain; Breast swelling; Sprain; This spontaneous case was reported by a nurse and describes the occurrence of BREAST DISCOMFORT (Breast heaviness), MUSCULOSKELETAL CHEST PAIN (chest pain), BREAST SWELLING (Breast swelling) and LIGAMENT SPRAIN (Sprain) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.    On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 09-Jan-2021, the patient experienced BREAST DISCOMFORT (Breast heaviness), MUSCULOSKELETAL CHEST PAIN (chest pain), BREAST SWELLING (Breast swelling) and LIGAMENT SPRAIN (Sprain). At the time of the report, BREAST DISCOMFORT (Breast heaviness), MUSCULOSKELETAL CHEST PAIN (chest pain), BREAST SWELLING (Breast swelling) and LIGAMENT SPRAIN (Sprain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: Hypertension. On an unknown date, Computerised tomogram: negative (Negative) Unclear. On an unknown date, Fibrin D dimer: d-dimer Elevated, rule out DVT. On an unknown date, X-ray: x-ray Not clear.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included motrin and Lidoderm patch.  No concomitant medication was provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain in extremity
Clinical narrative: Soreness of arm; Feeling fatigue; A spontaneous report was received from a consumer concerning a 63 years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced fatigue and soreness of arm. The patient's medical history was not provided.  No relevant concomitant medications were reported.    On 23-JAN-2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 042L20A) intramuscularly in an unknown anatomical location for prophylaxis of COVID-19 infection.  On 23-JAN-2021, The patient experienced fatigue. On 24-JAN-2021, the patient experienced soreness in arm. No Lab Details provided Treatment mentioned states she took Benadryl 12.5mg, Sudafed 30mg and Ibuprofen 200mg;  Action taken with mRNA-1273 in response to the events was not reported.  At the time of this report, the outcome of the event was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: a case of shingles; This spontaneous case was reported by a physician and describes the occurrence of HERPES ZOSTER (a case of shingles) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HERPES ZOSTER (a case of shingles). At the time of the report, HERPES ZOSTER (a case of shingles) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: very sore, stiff neck; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (very sore, stiff neck) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (very sore, stiff neck). At the time of the report, MUSCULOSKELETAL STIFFNESS (very sore, stiff neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Feeling hot, Lymph node palpable, Lymphadenopathy, Pain in extremity
Clinical narrative: swollen lymph nodes; Compared to yesterday, It is worse, more painful; It felt very warm; I was rubbing and I noticed the node; pain in left arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of FEELING HOT (It felt very warm) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (It felt very warm). At the time of the report, FEELING HOT (It felt very warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Myalgia, Pyrexia
Clinical narrative: Body aches; sleeplessness; Fever of 101 deg Farenheit; This spontaneous case was reported by a non-health professional and describes the occurrence of INSOMNIA (sleeplessness), PYREXIA (Fever of 101 deg Farenheit) and MYALGIA (Body aches) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced INSOMNIA (sleeplessness) and PYREXIA (Fever of 101 deg Farenheit). On an unknown date, the patient experienced MYALGIA (Body aches). At the time of the report, INSOMNIA (sleeplessness), PYREXIA (Fever of 101 deg Farenheit) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: Positve for COVID; Redness near the injection site; Warm near the injection site; Swollen ear the injection site; Itch near the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (Redness near the injection site), INJECTION SITE WARMTH (Warm near the injection site), INJECTION SITE SWELLING (Swollen ear the injection site), INJECTION SITE PRURITUS (Itch near the injection site) and COVID-19 (Positve for COVID) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (Redness near the injection site), INJECTION SITE WARMTH (Warm near the injection site), INJECTION SITE SWELLING (Swollen ear the injection site) and INJECTION SITE PRURITUS (Itch near the injection site). On 22-Jan-2021, the patient experienced COVID-19 (Positve for COVID). At the time of the report, INJECTION SITE ERYTHEMA (Redness near the injection site), INJECTION SITE WARMTH (Warm near the injection site), INJECTION SITE SWELLING (Swollen ear the injection site), INJECTION SITE PRURITUS (Itch near the injection site) and COVID-19 (Positve for COVID) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity
Clinical narrative: Sore arm; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and ERYTHEMA (Redness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and ERYTHEMA (Redness). At the time of the report, PAIN IN EXTREMITY (Sore arm) and ERYTHEMA (Redness) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.    This case was linked to MOD-2021-010096, MOD-2021-012697 (Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: No new information updated; Sender's Comments:  MOD-2021-010096:same reporter, different patient MOD-2021-012697:same reporter, different patient
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Asthenia, COVID-19, Depressed mood
Clinical narrative: loss of sense of taste; loss of sense of smell; weakness; myalgia; not feeling well; Positive COVID 19 result; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive COVID 19 result) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure (Taking medication for blood pressure) and Cholesterol (Taking medication for cholesterol). Concomitant products included VITAMIN C [ASCORBIC ACID], vitamin d and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced COVID-19 (Positive COVID 19 result). At the time of the report, COVID-19 (Positive COVID 19 result) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, SARS-CoV-2 test positive: positive. On 18-Jan-2021, SARS-CoV-2 test positive: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Concomitant medications also included unspecified medication for cholesterol and blood pressure.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, SARS-CoV-2 test positive
Clinical narrative: loss of sense of taste; loss of sense of smell; weakness; myalgia; not feeling well; Positive COVID 19 result; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Positive COVID 19 result) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure (Taking medication for blood pressure) and Cholesterol (Taking medication for cholesterol). Concomitant products included VITAMIN C [ASCORBIC ACID], vitamin d and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced COVID-19 (Positive COVID 19 result). At the time of the report, COVID-19 (Positive COVID 19 result) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Jan-2021, SARS-CoV-2 test positive: positive. On 18-Jan-2021, SARS-CoV-2 test positive: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Concomitant medications also included unspecified medication for cholesterol and blood pressure.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chest discomfort, Fatigue, Malaise, Pain
Clinical narrative: aching; sore; feeling sick; fatigue; heaviness on the chest; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aching), PAIN (sore), MALAISE (feeling sick), FATIGUE (fatigue) and CHEST DISCOMFORT (heaviness on the chest) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jan-2021, the patient experienced PAIN (aching), PAIN (sore), MALAISE (feeling sick), FATIGUE (fatigue), CHEST DISCOMFORT (heaviness on the chest) and ARTHRALGIA (joint pain). On 17-Jan-2021, PAIN (aching), PAIN (sore), MALAISE (feeling sick), FATIGUE (fatigue), CHEST DISCOMFORT (heaviness on the chest) and ARTHRALGIA (joint pain) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: Whole-body aches / Muscle pain; seems to have a fever; Chills; Fatigue; Arm hurt a little; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt a little), MYALGIA (Whole-body aches / Muscle pain), PYREXIA (seems to have a fever), CHILLS (Chills) and FATIGUE (Fatigue) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012220A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt a little). On 22-Jan-2021, the patient experienced MYALGIA (Whole-body aches / Muscle pain), PYREXIA (seems to have a fever), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, PAIN IN EXTREMITY (Arm hurt a little), MYALGIA (Whole-body aches / Muscle pain), PYREXIA (seems to have a fever), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Nausea
Clinical narrative: Nausea; Diarrhea; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of Nausea; Diarrhea; Dizziness  in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling
Clinical narrative: injection site itchy; had a lemon size redness at the injection site; injection site firm; injection site swelling; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (had a lemon size redness at the injection site), INJECTION SITE INDURATION (injection site firm), INJECTION SITE SWELLING (injection site swelling) and INJECTION SITE PRURITUS (injection site itchy) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (had a lemon size redness at the injection site), INJECTION SITE INDURATION (injection site firm) and INJECTION SITE SWELLING (injection site swelling). On 16-Jan-2021, the patient experienced INJECTION SITE PRURITUS (injection site itchy). On 16-Jan-2021, INJECTION SITE SWELLING (injection site swelling) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (had a lemon size redness at the injection site), INJECTION SITE INDURATION (injection site firm) and INJECTION SITE PRURITUS (injection site itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Rash
Clinical narrative: Rash; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (Rash) and FATIGUE (Fatigue). At the time of the report, RASH (Rash) and FATIGUE (Fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: slightly raised red area; swelling at the site of the injection; soreness in the arm; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of   in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Insulin dependent diabetic.    On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Vaccination site swelling
Clinical narrative: Dizziness; Fatigue; Swelling arm; This spontaneous case was reported by a consumer and describes the occurrence of   in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Diabetes. Concomitant products included CYANOCOBALAMIN (VITAMIN B12 [CYANOCOBALAMIN]) and VITAMIN D3 for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling, Pruritus, Vaccination site erythema, Vaccination site warmth
Clinical narrative: Arm itch; Red; Hot; swollen; A spontaneous report was received from a consumer who was also a 74-years-old male patient who received Moderna's COVID-19 vaccine and experienced events like arm started to itch, it was  swollen, red and hot,around the arm on deltoid.   Patient's medical history  and concomitant medicines was not provided.   On 12-JAN-2021,patient received Moderna's COVID-19 vaccine on his left arm intramuscularly at a drive thru vaccination site  Around the 18-JAN-2021 or 19-JAN-2021, her arm started to itch. On the 20-JAN-2021 it was swollen and on 22-JAN-2021  there was no itching but it is red and hot, around arm on the deltoid.   Treatment actions was not provided.  Action taken with mRNA-1273 was not reported.  The outcome of the events, arm started to itch was recovered/resolved, and  it was  swollen, red and hot,around the arm on deltoid was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Injection site pruritus, Injection site swelling, Pyrexia
Clinical narrative: headache; fever up to 101.5 ° F; swollen at the injection site; felt tired; itchiness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (itchiness at the injection site), INJECTION SITE SWELLING (swollen at the injection site), FATIGUE (felt tired), HEADACHE (headache) and PYREXIA (fever up to 101.5 ° F) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concomitant products included DULOXETINE for an unknown indication.    On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Jan-2021, the patient experienced INJECTION SITE PRURITUS (itchiness at the injection site). On 06-Jan-2021, the patient experienced INJECTION SITE SWELLING (swollen at the injection site) and FATIGUE (felt tired). On 16-Jan-2021, the patient experienced HEADACHE (headache) and PYREXIA (fever up to 101.5 ° F). On 07-Jan-2021, INJECTION SITE SWELLING (swollen at the injection site) and FATIGUE (felt tired) had resolved. On 19-Jan-2021, HEADACHE (headache) had resolved. On 21-Jan-2021, PYREXIA (fever up to 101.5 ° F) had resolved. At the time of the report, INJECTION SITE PRURITUS (itchiness at the injection site) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  Concomitant medication included lipid modifying agents.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Nausea
Clinical narrative: Felt fatigued; Nausea; Chills; Muscle ache; Really bad headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Felt fatigued), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Muscle ache) and HEADACHE (Really bad headache) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concomitant products included GALCANEZUMAB GNLM (EMGALITY [GALCANEZUMAB GNLM]) and AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced FATIGUE (Felt fatigued), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Muscle ache) and HEADACHE (Really bad headache). On 20-Jan-2021, FATIGUE (Felt fatigued), NAUSEA (Nausea), CHILLS (Chills), MYALGIA (Muscle ache) and HEADACHE (Really bad headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Red at the injection site; swollen at the injection site like a bump; itchy; This spontaneous case was reported by a pharmacist (subsequently medically confirmed) and describes the occurrence of   in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Fatigue, Malaise, Nausea
Clinical narrative: Nauseous; Extremely fatigued; Chills/ Shaking; Temperature went up to 102.3 degrees F/ Felt like she was on fire; Felt super weak; Felt really bad for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extremely fatigued), CHILLS (Chills/ Shaking), PYREXIA (Temperature went up to 102.3 degrees F/ Felt like she was on fire), ASTHENIA (Felt super weak) and NAUSEA (Nauseous) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pneumonia (Covid pneumonia in the history.) in March 2020.    On 16-Jan-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced CHILLS (Chills/ Shaking), PYREXIA (Temperature went up to 102.3 degrees F/ Felt like she was on fire), ASTHENIA (Felt super weak) and MALAISE (Felt really bad for 2 days). On 16-Jan-2021 at 1:00 PM, the patient experienced FATIGUE (Extremely fatigued). On 18-Jan-2021, the patient experienced NAUSEA (Nauseous). On 20-Jan-2021, FATIGUE (Extremely fatigued), CHILLS (Chills/ Shaking), PYREXIA (Temperature went up to 102.3 degrees F/ Felt like she was on fire), ASTHENIA (Felt super weak), NAUSEA (Nauseous) and MALAISE (Felt really bad for 2 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Nauseous; Extremely fatigued; Chills/ Shaking; Temperature went up to 102.3 degrees F/ Felt like she was on fire; Felt super weak; Felt really bad for 2 days; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extremely fatigued), CHILLS (Chills/ Shaking), PYREXIA (Temperature went up to 102.3 degrees F/ Felt like she was on fire), ASTHENIA (Felt super weak) and NAUSEA (Nauseous) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Pneumonia (Covid pneumonia in the history.) in March 2020.    On 16-Jan-2021 at 10:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced CHILLS (Chills/ Shaking), PYREXIA (Temperature went up to 102.3 degrees F/ Felt like she was on fire), ASTHENIA (Felt super weak) and MALAISE (Felt really bad for 2 days). On 16-Jan-2021 at 1:00 PM, the patient experienced FATIGUE (Extremely fatigued). On 18-Jan-2021, the patient experienced NAUSEA (Nauseous). On 20-Jan-2021, FATIGUE (Extremely fatigued), CHILLS (Chills/ Shaking), PYREXIA (Temperature went up to 102.3 degrees F/ Felt like she was on fire), ASTHENIA (Felt super weak), NAUSEA (Nauseous) and MALAISE (Felt really bad for 2 days) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus, Injection site warmth
Clinical narrative: redness at injection site; itchiness at injection site; injection site was also hard; injection site was hot; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE ERYTHEMA (redness at injection site), INJECTION SITE PRURITUS (itchiness at injection site), INJECTION SITE INDURATION (injection site was also hard) and INJECTION SITE WARMTH (injection site was hot) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (redness at injection site), INJECTION SITE PRURITUS (itchiness at injection site), INJECTION SITE INDURATION (injection site was also hard) and INJECTION SITE WARMTH (injection site was hot). At the time of the report, INJECTION SITE ERYTHEMA (redness at injection site), INJECTION SITE PRURITUS (itchiness at injection site), INJECTION SITE INDURATION (injection site was also hard) and INJECTION SITE WARMTH (injection site was hot) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was given Keflex, Benadryl, Pepcid by the doctor .   No concomitant medication was provided.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Diarrhoea, Headache, Myalgia, Pyrexia
Clinical narrative: diarrhea; first 24-48 she was feeling horrible; loss of apettite; myalgia; fever; vomiting; headache; rash in the back; This spontaneous case was reported by a health care professional and describes the occurrence of DECREASED APPETITE (loss of apettite) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced DECREASED APPETITE (loss of apettite). At the time of the report, DECREASED APPETITE (loss of apettite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took Tylenol and Benadryl as treatment.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Vaccination complication, Vomiting
Clinical narrative: diarrhea; first 24-48 she was feeling horrible; loss of apettite; myalgia; fever; vomiting; headache; rash in the back; This spontaneous case was reported by a health care professional and describes the occurrence of DECREASED APPETITE (loss of apettite) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced DECREASED APPETITE (loss of apettite). At the time of the report, DECREASED APPETITE (loss of apettite) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took Tylenol and Benadryl as treatment.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus, Vaccination site reaction
Clinical narrative: area is getting bigger; Warm to touch; Injected area was itching; Hardish; tenderness; Redness; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish) and VACCINATION SITE PAIN (tenderness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish), VACCINATION SITE PAIN (tenderness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling). At the time of the report, VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish), VACCINATION SITE PAIN (tenderness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: No specific follow-up information recorded.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: area is getting bigger; Warm to touch; Injected area was itching; Hardish; tenderness; Redness; Swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish) and VACCINATION SITE PAIN (tenderness) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.     On 13-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish), VACCINATION SITE PAIN (tenderness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling). At the time of the report, VACCINATION SITE REACTION (area is getting bigger), VACCINATION SITE WARMTH (Warm to touch), VACCINATION SITE PRURITUS (Injected area was itching), VACCINATION SITE INDURATION (Hardish), VACCINATION SITE PAIN (tenderness), VACCINATION SITE ERYTHEMA (Redness) and VACCINATION SITE SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 22-Jan-2021: No specific follow-up information recorded.
Sex: U
Vaccine: COVID19
Symptoms: Blood pressure increased
Clinical narrative: Elevated blood pressure; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Elevated blood pressure) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD PRESSURE INCREASED (Elevated blood pressure). At the time of the report, BLOOD PRESSURE INCREASED (Elevated blood pressure) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Age: 21.0
Sex: M
Vaccine: COVID19
Symptoms: Hypersensitivity, Vaccination complication
Clinical narrative: adverse events; possible allergic reaction; This spontaneous case was reported by an other health care professional and describes the occurrence of VACCINATION COMPLICATION (adverse events) and HYPERSENSITIVITY (possible allergic reaction) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (adverse events) and HYPERSENSITIVITY (possible allergic reaction). At the time of the report, VACCINATION COMPLICATION (adverse events) and HYPERSENSITIVITY (possible allergic reaction) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: from her neck to her arm is having intense pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (from her neck to her arm is having intense pain) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032l208) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MAGNESIUM, VITAMIN E NOS (VITAMIN E + MAGNESIUM), OMEPRAZOLE, blood pressure medication and blood sugar medication for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PAIN (from her neck to her arm is having intense pain). At the time of the report, PAIN (from her neck to her arm is having intense pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient took Tylenol to relieve the pain.   Reporter did not allow further contact
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Nasal congestion
Clinical narrative: Slight cough; Nasal congestion; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Slight cough) and NASAL CONGESTION (Nasal congestion) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunization.     No medical history was provided by the reporter.     On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COUGH (Slight cough) and NASAL CONGESTION (Nasal congestion). At the time of the report, COUGH (Slight cough) and NASAL CONGESTION (Nasal congestion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema
Clinical narrative: redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (redness at the injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (redness at the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.   Reporter did not allow further contact
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Skin burning sensation, Vaccination site rash
Clinical narrative: right palm pain felt like it had a hot poker in it, rating 8-9; reports pain down her right arm; itchy rash; started to have a rash, smooth, reasonably hard, very itchy, and grew; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE RASH (started to have a rash, smooth, reasonably hard, very itchy, and grew), SKIN BURNING SENSATION (right palm pain felt like it had a hot poker in it, rating 8-9), PAIN IN EXTREMITY (reports pain down her right arm) and VACCINATION SITE RASH (itchy rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced VACCINATION SITE RASH (started to have a rash, smooth, reasonably hard, very itchy, and grew) and VACCINATION SITE RASH (itchy rash). On an unknown date, the patient experienced SKIN BURNING SENSATION (right palm pain felt like it had a hot poker in it, rating 8-9) and PAIN IN EXTREMITY (reports pain down her right arm). At the time of the report, VACCINATION SITE RASH (started to have a rash, smooth, reasonably hard, very itchy, and grew), PAIN IN EXTREMITY (reports pain down her right arm) and VACCINATION SITE RASH (itchy rash) outcome was unknown and SKIN BURNING SENSATION (right palm pain felt like it had a hot poker in it, rating 8-9) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site infection, Vaccination site rash
Clinical narrative: Very strange rash. It was 3 inches*1.5 inches wide; Infection in right arm just where nurse gave the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Very strange rash. It was 3 inches*1.5 inches wide) and VACCINATION SITE INFECTION (Infection in right arm just where nurse gave the vaccine) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included APIXABAN (ELIQUIS) for an unknown indication.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (Very strange rash. It was 3 inches*1.5 inches wide) and VACCINATION SITE INFECTION (Infection in right arm just where nurse gave the vaccine). At the time of the report, VACCINATION SITE RASH (Very strange rash. It was 3 inches*1.5 inches wide) and VACCINATION SITE INFECTION (Infection in right arm just where nurse gave the vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.